STIMULATION OF THE T-CELL ANTIGEN RECEPTOR-CD3 COMPLEX SIGNALING PATHWAY BY THE TYROSINE PHOSPHATASE INHIBITOR PERVANADATE IS MEDIATED BY INHIBITION OF CD45 - EVIDENCE FOR 2 INTERCONNECTED LCK FYN-DEPENDENT ORZAP-70-DEPENDENT SIGNALING PATHWAYS/
V. Imbert et al., STIMULATION OF THE T-CELL ANTIGEN RECEPTOR-CD3 COMPLEX SIGNALING PATHWAY BY THE TYROSINE PHOSPHATASE INHIBITOR PERVANADATE IS MEDIATED BY INHIBITION OF CD45 - EVIDENCE FOR 2 INTERCONNECTED LCK FYN-DEPENDENT ORZAP-70-DEPENDENT SIGNALING PATHWAYS/, Journal of inflammation, 46(2), 1996, pp. 65-77
The tyrosine phosphatase specific inhibitor pervanadate is a potent ac
tivator of T lymphocytes through induction of tyrosine phosphorylation
and downstream events of the activation cascade. Using CD45- or CD3-n
egative variants of the Jurkat leukemic T-cell line rue show that the
different biochemical events induced by pervanadate appeared to be dep
endent on the presence at the cell surface of either CD45 or CD3. CD45
-dependent events such as tyrosine phosphorylation of Shc, activation
of nuclear factor-kappa B (NF-kappa B), activator protein 1 (AP-1), tr
anscription factors, and stimulation of interleukin-2 (IL-2) promoter
and of CD69 and CD25 surface expression paralleled activation of the t
yrosine kinases lck and fyn. By contrast, stimulation of calcium influ
x, a CD3-dependent event, paralleled zap-70 activation. The data demon
strate that the T-cell antigen receptor-CD3 (TcR-CD3) complex is funct
ionally linked to two different protein tyrosine kinase (PTK) modules
with separate specific functions and that CD45 may bean important regu
lator of this coupling. (C) 1996 Wiley-Liss, Inc.